France· FR:67023718
SEVIKAR 20 mg/5 mg, comprimé pelliculé
A medicinal product containing olmésartan médoxomil + bésilate d'amlodipine, registered in France by DAIICHI SANKYO FRANCE.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- OLMÉSARTAN MÉDOXOMIL + BÉSILATE D'AMLODIPINE
- Manufacturer
- DAIICHI SANKYO FRANCE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
- cip133400938858266plaquette(s) polyamide aluminium PVC-Aluminium de 30 comprimé(s)
- cip133400938858495plaquette(s) polyamide aluminium PVC-Aluminium de 90 comprimé(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Olmésartan médoxomil + bésilate d'amlodipine in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaOLMESARTAN/AMLODIPIN ZENTIVAZentiva, k.s., Praha
- United StatesAmlodipine and olmesartan MedoxomilAscend Laboratories, LLC
- ItalyBIVISMENARINI INTERNAT. O.L.S.A
- GermanyOlmeamloTad Pharma Gmbh
- FinlandAleaMenarini International Operations Luxembourg S.A.
- IrelandKonverge 20 mg/5 mg film-coated tabletsMenarini International Operations Luxembourg S.A.
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Amelior, Olmesartan/Amlodipin 1a Pharma
- Belgium · Forzaten, Forzaten®
- Bulgaria · Amlodipine Besilate / Olmesartan Medoxomil Viatris Limited, Амлосарт
- Cyprus · Alsamod, Comprelan
- Czechia · Olmesartan/Amlodipin Zentiva, Olssa
- Germany · Olmeamlo, Olmeamlodipin Puren
- Estonia · Olmesartan Medoxomil/Amlodipine Accord, Olmesartan Medoxomil/Amlodipine Zentiva
- Spain · Albis, Balzak
- Finland · Olmesartan Medoxomil/Amlodipine Krka
- United Kingdom (Northern Ireland) · Olmesartan Medoxomil And Amlodipine Clydesdale Pharma, Olmesartan Medoxomil/Amlodipine Accord Healthcare
- Greece · Comprelan, Olmedipin
- Croatia · Olmita
- Hungary · Duactan, Olmiza
- Ireland · Konverge, Olmesartan /Amlodipine Mylan
- Italy · Bivis, Giant
- Lithuania · Olmesartan Medoxomil /Amlodipine Sandoz, Olmesartan Medoxomil/Amlodipine Accord
- Luxembourg · Forzaten, Olmesartan/Amlodipine Eg
- Latvia · Olmesartan Medoxomil/ Amlodipine Zentiva, Olssa
- Malta · Konverge, Olmesartan Medoxomil/Amlodipine Ascend
- Netherlands · Amlodipine Besylate/ Olmesartan Medoxomil Aurobindo, Amlodipine Besylate/Olmesartan Medoxomil Aurobindo
- Poland · Elestar, Olmita
- Portugal · Amlodipina + Olmesartan Medoxomilo Alter, Amlodipina + Olmesartan Medoxomilo Aurovitas
- Romania · Almacor Duo, Inovum
- Slovenia · Olectan, Olmita
- Slovakia · Folgan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6dc051c8-4cc6-4af6-8b3b-871cc2e04795 GET /v1/drugs/6dc051c8-4cc6-4af6-8b3b-871cc2e04795?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67023718",
"date_amm": "2008-10-03",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "OLMÉSARTAN MÉDOXOMIL + BÉSILATE D'AMLODIPINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about olmésartan médoxomil + bésilate d'amlodipine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.